Given the critical dual role of TGFβ in limiting autoimmune and anti-tumor responses, we investigated the impact of PTPN22 deficiency on the responses of CD8+ T cells to this key inhibitory cytokine. The gene discussed is CD8A; the disease is neoplasm.